3rd Quarter - Report

LIBERTY PARTNERS GROUP, LLC for TELIX PHARMACEUTICALS US

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

LobbyistCovered position, as disclosed
ANDREW COATS Legislative Assistant, Rep. Mark Souder
ANDREW L WOODS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

LobbyistCovered position, as disclosed
ANDREW COATS Legislative Assistant, Rep. Mark Souder
ANDREW L WOODS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

LobbyistCovered position, as disclosed
ANDREW COATS Legislative Assistant, Rep. Mark Souder
ANDREW L WOODS —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.